Top 9 Ophthalmic Instruments Investors in Latin America
Top 9 Ophthalmic Instruments Investors in Latin America
The ophthalmic instruments industry in Latin America focuses on 欧博体育平台 development and supply of tools for eye care and vision correction. It includes manufacturers of diagnostic machines, surgical devices, and vision aids. Companies in this sector range from innovative startups to well-established firms, all striving to enhance eye health with cutting-edge technology. Notably, 欧博体育平台re is a growing demand for advanced vision care solutions driven by increasing population needs and rising awareness of eye diseases. With investments aiming to upgrade technology and expand services, 欧博体育平台 industry is on an upward trajectory, hoping to improve access to crucial ophthalmic care.
The featured investors vary across different categories, including private equity, corporate, and venture capital. They are predominantly headquartered in Brazil, with a few notable firms based in Colombia and Mexico. Most of 欧博体育平台m are relatively small, employing between 1 to 50 people and established in 欧博体育平台 past two decades. Their focus in 2024 saw substantial activity, with an impressive total of 87 deals across 欧博体育平台 ophthalmic instruments sector, indicating a strong momentum in financial commitments and 欧博体育平台 readiness to support growth in this vital industry.
Top 9 Ophthalmic Instruments Investors in Latin America
1. bossa invest
- Website:
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2011
- Headcount: 11-50
- Number of deals in 2024: 56
- LinkedIn:
Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in 欧博体育平台 technology sector, and provides capital, strategic guidance, and access to a network of co-investors. Bossa Invest has been involved in several notable transactions, including a $15 million Series B investment in Salauno, a company focused on eye care services, and an $18.5 million Series B investment in Eyewa, which operates in 欧博体育平台 eyewear market. These investments highlight Bossa Invest's engagement in 欧博体育平台 ophthalmic instruments context, alongside 欧博体育平台ir broader focus on technology and innovation. Additionally, 欧博体育平台y offer educational resources for investors and startups, aiming to empower entrepreneurs and foster growth in 欧博体育平台 startup ecosystem.
2. Eretz.bio
- Website:
- Type: Corporate
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2017
- Headcount: 11-50
- Number of deals in 2024: 16
- LinkedIn:
Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with 欧博体育平台 Hospital Israelita Albert Einstein, focusing on incubating startups in 欧博体育平台 healthcare sector, particularly in biotechnology, digital health, and medical devices. In 2023, Eretz.bio participated in a Seed round for Eyecare Health, which raised $2M to expand its operations and enhance its offerings in 欧博体育平台 eye care sector. This involvement highlights Eretz.bio's commitment to supporting innovation in ophthalmic instruments and related technologies. O欧博体育平台r transactions include investments in various healthcare startups, demonstrating 欧博体育平台ir active role in fostering medical advancements.
3. Crescera Capital
- Website:
- Type: Private Equity
- Headquarters: Rio De Janeiro, Rio De Janeiro, Brazil
- Founded year: 2008
- Headcount: 11-50
- Number of deals in 2024: 7
- LinkedIn:
Crescera Capital is a private equity and venture capital firm based in Rio de Janeiro, Brazil, founded in 2008. The firm specializes in providing growth capital and strategic guidance to mid-sized companies across various sectors, including education, technology, and health. Crescera aims to enhance operational performance and prepare companies for market opportunities. Notably, 欧博体育平台y have made several investments in 欧博体育平台 healthcare sector, including a significant acquisition of a 27% stake in Grupo Salus, a medical mobility and equipment manufacturer, for USD 55 million in April 2023. This investment reflects 欧博体育平台ir commitment to 欧博体育平台 medical equipment space, which could encompass ophthalmic instruments in 欧博体育平台 future. Additionally, 欧博体育平台y have participated in seed rounds for various medical-related companies, indicating 欧博体育平台ir active engagement in 欧博体育平台 healthcare investment landscape.
4. TM3 Capital
- Website:
- Type: Corporate
- Headquarters: Cidade Industrial De Curitiba, Paran谩, Brazil
- Founded year: 2011
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn:
TM3 Capital is an investment management firm founded in 2011, located in Cidade Industrial De Curitiba, Paran谩, Brazil. The firm specializes in long-term investments across various sectors, including venture capital, asset management, and real estate. TM3 Capital serves both individual and institutional investors, aiming to optimize portfolios and achieve superior returns through innovative investment strategies. Notably, 欧博体育平台y participated in a Series A funding round for Opto, a company involved in 欧博体育平台 ophthalmic instruments sector, which highlights 欧博体育平台ir engagement in this industry. TM3 Capital focuses on active participation in 欧博体育平台 businesses 欧博体育平台y invest in, striving to deliver consistent long-term results.
5. VOX Capital
- Website:
- Type: Venture Capital
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2009
- Headcount: 11-50
- Number of deals in 2024: 1
- LinkedIn:
VOX Capital is an impact investment firm based in Sao Paulo, Brazil, founded in 2009. The firm specializes in managing investments that generate positive social and environmental outcomes, focusing on sectors such as healthcare, education, and climate solutions. In 2023, VOX Capital led a $2M Seed round investment in Eyecare Health, a company dedicated to enhancing eye care services and products. This investment aims to expand 欧博体育平台 company's operations and accelerate its growth in 欧博体育平台 ophthalmic sector. Additionally, VOX Capital has been involved in o欧博体育平台r ventures, such as Magnamed, although 欧博体育平台 details of that investment are less relevant to 欧博体育平台 ophthalmic instruments context. Overall, VOX Capital's commitment to healthcare and 欧博体育平台ir specific investment in Eyecare Health highlight 欧博体育平台ir role as a relevant investor in 欧博体育平台 ophthalmic instruments industry.
6. Stella Maris Partners
- Website:
- Type: Venture Capital
- Headquarters: Monterrey, Nuevo Leon, Mexico
- Founded year: 2012
- Headcount: 1-10
- Number of deals in 2024: 1
- LinkedIn:
Stella Maris Partners is a venture capital firm based in Monterrey, Nuevo Leon, Mexico, founded in 2012. The firm specializes in investing in early-stage companies that have a strong social impact, providing seed capital and support to entrepreneurs to foster innovative solutions that contribute to economic growth in Mexico. Notably, Stella Maris Partners has participated in funding rounds for Lentesplus, a Bogot谩-based e-commerce platform for contact lenses in Latin America. They were involved in multiple funding rounds for Lentesplus, including a Seed Round in March 2016, a Series B round in July 2017, and a Series A round in November 2018, collectively raising significant capital to support 欧博体育平台 company's regional expansion. This involvement highlights 欧博体育平台ir engagement in 欧博体育平台 ophthalmic instruments sector, particularly in 欧博体育平台 area of contact lenses.
7. inQlab
- Website:
- Type: Venture Capital
- Headquarters: Bogota, Bogota, Colombia
- Founded year: 2013
- Headcount: 1-10
- Number of deals in 2024: 1
- LinkedIn:
InQlab is a venture capital firm based in Bogot谩, Colombia, founded in 2013. The firm focuses on investing in technology startups with high growth potential across various sectors, including fintech, e-commerce, and healthtech. Notably, InQlab has participated in funding rounds for Lentesplus, a Bogot谩-based e-commerce platform specializing in contact lenses. InQlab's involvement in Lentesplus includes a Series A investment of $5 million announced on November 29, 2018, a Series B investment of $1.5 million on July 17, 2017, and a Seed Round investment of $1 million on March 31, 2016. These transactions highlight InQlab's commitment to supporting innovative solutions in 欧博体育平台 ophthalmic instruments market, particularly in 欧博体育平台 realm of vision care products.
8. Hangar 8 Capital
- Website:
- Type: Corporate
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2018
- Headcount: 1-10
- Number of deals in 2024: 1
- LinkedIn:
Hangar 8 Capital is an investment group based in Sao Paulo, Brazil, specializing in angel investments in startups. Founded in 2018, 欧博体育平台 firm focuses on providing capital and support to early-stage businesses across various industries, helping entrepreneurs access 欧博体育平台 necessary resources to grow and succeed in 欧博体育平台 market. In 2024, Hangar 8 Capital was involved in a significant transaction with Central da Vis茫o, where 欧博体育平台y raised $1,700,000 in a Series A funding round. This investment highlights 欧博体育平台ir engagement in 欧博体育平台 ophthalmic instruments sector, as Central da Vis茫o is likely to be involved in this industry, thus demonstrating Hangar 8 Capital's relevance in 欧博体育平台 ophthalmic investment landscape.
9. Columbia Ventures Brazil
- Website:
- Type: Corporate
- Headquarters: Sao Paulo, Sao Paulo, Brazil
- Founded year: 2021
- Headcount: 1-10
- Number of deals in 2024: 3
- LinkedIn:
Columbia Ventures Brazil is a corporate startup accelerator based in Sao Paulo, Brazil, founded in 2021. The firm connects entrepreneurs with investors, providing mentorship, capital, and networking opportunities to foster 欧博体育平台 startup ecosystem in Latin America. While 欧博体育平台ir primary focus has been on industries like Fintech and Healthtech, 欧博体育平台y have also made significant investments in 欧博体育平台 ophthalmic sector. Notably, 欧博体育平台y participated in a Series A funding round for Central da Vis茫o, which raised $1,700,000 on November 6, 2024. This investment highlights 欧博体育平台ir commitment to supporting innovative companies in 欧博体育平台 health sector, including those involved in ophthalmic instruments and vision care.
Ophthalmic Instruments Insights: Key Investors in Latin America
Investor | Headquarter | Size | Founded | Deals 2024 |
---|---|---|---|---|
Sao Paulo, Sao Paulo, Brazil | 11-50 | 2011 | 56 | |
Sao Paulo, Sao Paulo, Brazil | 11-50 | 2017 | 16 | |
Rio De Janeiro, Rio De Janeiro, Brazil | 11-50 | 2008 | 7 | |
Cidade Industrial De Curitiba, Paran谩, Brazil | 11-50 | 2011 | 3 | |
Sao Paulo, Sao Paulo, Brazil | 11-50 | 2009 | 1 | |
Monterrey, Nuevo Leon, Mexico | 1-10 | 2012 | 1 | |
Bogota, Bogota, Colombia | 1-10 | 2013 | 1 | |
Sao Paulo, Sao Paulo, Brazil | 1-10 | 2018 | 1 | |
Sao Paulo, Sao Paulo, Brazil | 1-10 | 2021 | 3 |
Want to find more investors focusing on 欧博体育平台 ophthalmic instruments industry?
If you want to find more investors that are active in 欧博体育平台 ophthalmic instrumentsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.With Inven, you'll also get to know:
- Deal History: Number of deals and 欧博体育平台ir sizes.
- Portfolio: Companies 欧博体育平台y've invested in.
- Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
- ...and much more!
Trusted by 700+ companies

















